Legal, Regulatory and Licensing Risks in the Dispensing Pharmacy Business
First written in FY2018. 4 of 6 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2021: 2 of 14 companies on the "Worse" side.
16 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The operation of prescription pharmacies is subject to legal regulations under the Pharmaceuticals and Medical Devices Act and the Health Insurance Act, with strict compliance requirements. The main requirements are a pharmacy establishment license and designation as an insurer-designated pharmacy; other permits and designations must also be obtained from prefectural governors and other authorities.」
The company continues to disclose legal, regulatory and licensing risks, including pharmacy establishment licenses and designation as an insurer-designated pharmacy. - FY2025RestatedAnnual report
「The operation of prescription pharmacies is subject to legal regulations under the Pharmaceuticals and Medical Devices Act and the Health Insurance Act, with strict compliance requirements. The main requirements are a pharmacy establishment license and designation as an insurer-designated pharmacy; other permits and designations must also be obtained from prefectural governors and other authorities.」
The company continues to disclose legal, regulatory and licensing risks, including pharmacy establishment licenses and designation as an insurer-designated pharmacy. - FY2023RestatedAnnual report
「The operation of prescription pharmacies is subject to legal regulations under the Pharmaceuticals and Medical Devices Act and the Health Insurance Act, with strict compliance requirements. The main requirements are a pharmacy establishment license and designation as an insurer-designated pharmacy; other permits and designations must also be obtained from prefectural governors and other authorities.」
The company continues to disclose legal, regulatory and licensing risks in the prescription pharmacy business, including pharmacy establishment licenses and designation as an insurer-designated pharmacy. - FY2022-Q1ReframedAnnual report
「Since August 2021, following the partial enforcement of the amended Pharmaceuticals and Medical Devices Act, the business has faced major changes, including the introduction of a function-based pharmacy certification system to enable patients to choose pharmacies suited to their needs.」
The disclosure of legal, regulatory and licensing risks in the prescription pharmacy business incorporates the new regulatory environment created by the partial enforcement of the amended Pharmaceuticals and Medical Devices Act, the function-based certification system and the obligation to establish legal compliance systems. - FY2019RestatedAnnual report
「The operation of prescription pharmacies is subject to legal regulations under the Pharmaceuticals and Medical Devices Act and the Health Insurance Act, with strict compliance requirements.」
The company continues to disclose the potential impact on financial results of legal and regulatory requirements, licensing, and amendments to or violations of laws in the prescription pharmacy business. - FY2018First statedAnnual report
「The operation of prescription pharmacies is subject to legal regulations under the Pharmaceuticals and Medical Devices Act and the Health Insurance Act, with strict compliance requirements.」
The company states that violations or amendments of legal, regulatory and licensing requirements, including pharmacy establishment licenses and designation as an insurer-designated pharmacy, may affect financial results.